Headline
The latest stories from AHA Today.
Pfizer released the first data evaluating a COVID-19 vaccine’s safety and effectiveness for children between the ages of 5 and 11.
The Centers for Medicare & Medicaid Services released a final rule with additional policies for health insurance issuers and the Health Insurance Marketplaces for plan years 2022 and beyond.
The Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee by a unanimous vote recommended that the FDA issue an emergency use authorization that would enable COVID-19 vaccine boosters for individuals age 65 and older and those at high risk for severe COVID-19,…
Percy Allen II, past president of the National Association of Health Services Executives, died Sept. 12 at age 80. Among other leadership positions, he served as assistant administrator at Parkview Memorial Hospital in Ft. Wayne, Ind.; CEO at North Central Bronx Hospital in New York; vice president…
The AHA and its Institute for Diversity and Health Equity are now accepting applications for the 2022 Carolyn Boone Lewis Equity of Care Awards. The awards recognize hospitals and health systems that are proactive in advancing diversity, health equity and equitable health care through data,…
Rep. Haley Stevens, D-Mich., and Sen. Debbie Stabenow, D-Mich., introduced a bicameral resolution designating Sept. 17 as National Physician Suicide Awareness Day.
The Centers for Disease Control and Prevention revealed the comparative effectiveness of the three Food and Drug Administration-authorized COVID-19 vaccines, with Moderna’s vaccine deemed most effective at preventing hospitalizations.
The Health Resources and Services Administration awarded $342 million to expand home visiting services to pregnant women and parents with young children in U.S. states and territories.
Health care providers and patients should not use compounded products marketed as sterile by Greenpark Compounding Pharmacy due to a lack of sterility assurance, the Food and Drug Administration announced.
The Centers for Disease Control and Prevention will invest $2.1 billion from the American Rescue Plan Act to help public health and other partners fight COVID-19 and other emerging infections in health care facilities, the Biden Administration announced.